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Abstract All patients with T1 and T2 laryngeal cancer
should be treated with the intent to preserve the larynx. In
T3 glottic low-volume tumors, larynx preservation is an
appropriate standard treatment option. Supracricoid partial
laryngectomy remains a reasonable alternative to radiother-
apy for patients with T2–T3 glottic cancer. Prospective
clinical study aims to evaluate the oncological results of
supracricoid partial laryngectomy as a treatment for
selected glottic and supraglottic carcinoma, and to deter-
mine the diVerent prognostic factors that may inXuence
local control and survival. In the period of 2000–2007, 145
patients were treated at the academic tertiary referral medi-
cal center: ENT Department, University of Medical Sci-
ences, Poznán, Poland. The ages of the analyzed group of
patients ranged from 23 to 79, with mean 56.5 age for men
and 25 for women. All of the patients had biopsy proven
squamous cell carcinoma. Of the 145 patients 82 had glottic
cancer and 63 had supraglottic cancer. The patients were
staged according to the 2003 edition of the TNM classiWca-
tion established by the AJCC. The pathological TNM clas-
siWcation was additionally taken into consideration. All
patients were treated by means of supracricoid and trans-
glottic partial laryngectomy. The type of supracricoid par-
tial laryngectomy was based on tumor localization and
extension. Four patients underwent cricohyoidopexy, 57
cricohyoidoepiglottopexy, 65 reconstruction modo Calearo,
and 19 modo Sedlacek-Tucker. We performed 21 unilateral
selective neck dissections and none bilateral. A nasogastric
feeding tube was inserted in all patients, and removed in
patients that regained proper swallowing. As a result, we
took into consideration the oncological and functional
results. Histopathological examination of the operating
specimen revealed the presence of dysplasia or invasive
carcinoma at the margins, or a close margin of less than
5 mm from the edge of the resection (16 cases). The metas-
tases were found on the neck in three cases, predominantly
in the level II (2 cases) and III (1 case). Metastasis was
found in one patient that had undergone CHP, Sedlacek-
Tucker, and Calearo, respectively. Five patients received
postoperative radiotherapy. The decision to use adjuvant
radiotherapy was based on the presence of invasive carci-
noma at the resection margin and on the presence of multi-
ple positive neck nodes or extracapsular spread of the
disease. The Kaplan–Meier estimated 3- and 5-year overall
survival rates in the group of 122 because 23 patients did
not report for medical check-ups.
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Introduction
All patients with T1 and T2 laryngeal cancer should be
treated with the intent to preserve the larynx. In T3 glottic
low-volume tumors, larynx preservation is an appropriate
standard treatment option. Patients with T2N0 squamous
cell carcinoma of the glottic larynx may be treated with
transoral laser surgery, open partial laryngectomy or radio-
therapy. Organ preservation policy in the treatment of low-
volume T3 glottic cancer follows the two last methods. The
goals of treatment are curing and laryngeal function preser-
vation: breathing, swallowing and optimal voice quality.
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Additional goals include minimizing the risk of serious
complications and cost eVectiveness. However, laser resec-
tion of larger tumors will probably result in better out-
comes. The rates of local control and survival are
comparable for open partial laryngectomy and radiotherapy
[1]. One of the most important issues is an easy access to
the particular treatment method. Whereas, for organization
reasons, radiotherpy or radiochemotherapy could be admin-
istered in 2-month time and targeted therapies are deWnitely
too expensive, supracricoid partial laryngectomy remains a
reasonable alternative for patients with T2–T3 glottic can-
cer. The SCL procedure is based on the preservation of the
cricoid cartilage, the hyoid bone, and at least one functional
cricoarytenoid unit (arytenoid cartilage, cricoid cartilage,
cricoarytenoid musculature, recurrent laryngeal nerve, and
superior laryngeal nerve). This structure must be free from
tumor invasion. This is necessary to preserve the airway
and the laryngeal sphincteric function, and to avoid a per-
manent tracheotomy. A thorough application of the indica-
tion is the basis of functional and oncological success in
this kind of surgery.
Aim of this study is to evaluate the oncological results of
supracricoid partial laryngectomy as a treatment for
selected glottic carcinoma and to determine the diVerent
prognostic factors that may inXuence local control and sur-
vival. The additional concern is the length of hospitalisa-
tion and total hospital costs.
Material
Material include 145 patients treated in academic tertiary
referral medical center: Department of Otolaryngology,
Poznaj University of Medical Sciences in the period of
January 2000–December 2007 due to cancer of the larynx.
The age of the analyzed group of patients ranged from
20 to 79, with mean age 56.5 for 35 men and 25 women.
All of the patients had biopsy proven squamous cell carci-
noma. Of the 145 patients, 82 had glottic cancer and 63 had
supraglottic cancer. The patients were staged according to
the 2003 edition of the TNM classiWcation established by
the AJCC. The pathological TNM classiWcation was addi-
tionally taken into consideration. Patient characteristics and
the analysis of locoregional advancement were shown in
Tables 1, 2.
Methods
There were four techniques of larynx reconstructive sur-
gery applied in the presented group. The type of supracri-
coid partial laryngectomy was based on tumor localization
and extension. Patient evaluation consisted of a complete
clinical history and physical examination with emphasis on
local tumor advancement (videolaryngoscopy, CT, indirect
laryngoscopy, microlaryngoscopy according to Kleinsas-
ser) and neck assessment (B-mode ultrasonography with
7 MHz linear probe). All patients underwent chest radio-
graph. All patients were treated by means of supracricoid
partial laryngectomy. Four patients underwent cri-
cohyoidopexy, 57 cricohyoidoepiglottopexy, 65 recon-
struction according to Calearo, and 19 according to
Sedlacek-Tucker. We performed 21 unilateral selective
neck dissections and none bilateral. A nasogastric feeding
tube was inserted in all patients, and removed in patients
that regained proper swallowing.
The indications and contraindication for particular tech-
niques are as follows.
Indications to supracricoid laryngectomy with CHEP
• glottic tumors classiWed as T2 due to tumor extension to
the ventricle, false vocal cord, petiole of epiglottis, ante-
rior aspect of the arytenoid cartilage, and/or impaired
true vocal cord,
• glottic tumors classiWed as T3 due to Wxation of the true
vocal cord without Wxation of the arytenoid cartilage.
With CHP—transglottic and supraglottic tumors classiWed
as T2 not amenable to supraglottic partial laryngectomy
due to ventricle invasion, glottis extension and/or impaired
motion of the true vocal cord.
• transglottic and supraglottic tumors classiWed as T3 due
to true vocal cord Wxation and/or preepiglottic space
invasion but without Wxation of the arytenoid cartilage,
• glottic tumors originating from the anterior commissure
with preepiglottic space invasion classiWed as T3.
Table 1 Patient characteristics
Criteria Patients
Total no. 145
Age 20–79
Radiotheraphy
Preoperative 0
Postoperative 5
Table 2 Locoregional advancement
Primary tumor staging
T2 115
T3 30
Primary tumor subsite
Glottic 82
Supraglottic 63Eur Arch Otorhinolaryngol (2011) 268:879–883 881
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Indication to transglottic laryngectomy according to Calero
Glottic space carcinoma extending on both sides with Wxa-
tion of one vocal cord and limiting vocal cord movement.
Indication to transglottic laryngectomy according to
Sedlacek-Tucker Glottic space carcinoma extending on one
side with Wxation of vocal cord and inWltration of the ante-
rior commissure.
Major contraindication to any reconstructive laryngec-
tomy include:
• Arytenoid cartilage Wxation
• Infraglottic extent of tumor reaching the upper border of
cricoid cartilage
• Cricoid cartilage invasion
• Invasion of outer perichondrium of the thyroid cartilage
• Hyoid bone invasion
• Major preepiglottic space invasion presenting clinically
with bulbing vallecula and/or bulbing thyrohyoid mem-
brane
• Extralaryngeal spread of tumor
Results
The analysis of locoregional advancement of the examined
group is shown in Table 3.
Only four patients were qualiWed for the CHP technique.
This choice was not preferred because of severe side eVects
including serious swallowing problems and low possibility
of successful decannulation, so these patients were sent to
primary radiotherapy (Table 4).
We took into consideration, the oncological and func-
tional results.
Histopathological examination of the operating speci-
men revealed presence of dysplasia or invasive carcinoma
at the margins or less than 5 mm from the edge of the resec-
tion (close margin) in 16 cases.
The metastases on the neck were found in 5 cases, pre-
dominantly in the level II and III. Metastasis was found in
one patient that had undergone CHP, Sedlacek-Tucker, and
Calearo, respectively.
The decision to use adjuvant radiotherapy was based on
the presence of invasive carcinoma at the resection margin
and on the presence of multiple positive neck nodes or
extracapsular spread of the disease. Five patients received
postoperative radiotherapy. There were 11 cases (7.58%) of
locoregional recurrences: 6 cases at the primary site and 5
cases at the neck lymph node. Total laryngectomy due to
local recurrences was performed in every case. In coinci-
dence of neck metastases, radical neck dissections were
performed. One patient died of laryngeal cancer due to
local recurrence. None of the patients died due to neck
metastases. One died due to pulmonary metastases, three
died due to perioperative complications (2 haemorrhagia, 1
pulmonary embolism), four patients died of causes not
related to laryngeal cancer. In four patients, a second pri-
mary tumor was observed. In one case, the tumor involved
the base of the tongue, in one the tonsil, in one the palate.
The Kaplan–Meier survival curves in a group of patients
showed a probability of 3-year survival rate 93.44%, and a
probability of 5-year survival rate 92.62% (Fig. 1).
InXuence of prognostic factor on oncological result We
performed univariate and multivatriate statistical analysis
of diVerent prognostic factors in terms of local and survival
in our 145 patients treated with supracricoid and transgloit-
tic laryngectomy.
In our group the mean and median length of stay were,
respectively, 21–31 days.
The most often reason of prolonged hospitalization was
diYculty in rehabilitation of swallowing, mostly after supr-
acricoid laryngectomy with CHEP or CHP
Healing Immediate postoperative complications included
anterior neck abscess, and persistent arytenoid edema.
Persistent arytenoid edema was successfully managed with
steroids in 25 cases, requiring laser vaporization in 19
cases. Anterior neck abscess were treated with prolonged
antibiotic therapy.
Decannulation In our examined group 135 patients were
decannulated. Retracheotomy was performed in 27 patients
beacuse of arytenoid cartilage edema and granulation tissue
in the pexy region. The mean decannulation time was
9.28 days. 17 patients had still tracheostomies.
Swallowing rehabilitation Usually we start swallowing
rehabilitation 14 days after surgery with food of a soft
Table 3 TNM classiWcation for supracricoid laryngectomies
CHP cricohyoidopexy, CHEP cricohyoidoepiglottopexy, LC laryn-
gectomy with reconstruction according to Calearo, LS-T laryngectomy
with reconstruction according to Sedlacek-Tucker
cTNM CHP CHEP LC LS-T pTNM CHP CHEP LC LS-T
T2N0 0 33 63 15 T2N0 0 30 56 12
T2N1 0 1 2 1 T2N1 0 1 2 1
T2N2 0 0 0 0 T2N2 0 0 0 0
T3N0 3 23 0 2 T3N0 3 23 5 4
T3N1 1 0 0 1 T3N1 0 1 0 0
T4N0 0 2 0 1
T4N1 1 0 0 1
Table 4 Final pathology
Squamous cell carcinoma 145
Decannulation 135
Selective neck dissection
Unilateral 21
Bilateral –882 Eur Arch Otorhinolaryngol (2011) 268:879–883
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consistency. Successful deglutition by the Wrst postopera-
tive month was achieved in 61.37%. Temporary grade 1–2
aspiration, according to the scale used by Pearson and Leip-
zig, occurred in 21.37%. Pneumonia due to aspiration
(grade 3) occurred in 17.24% of cases. Gastrostomy
because of grade 3 aspiration was necessary in one patient.
One year after surgery all our patients had obtained normal
deglutition without aspiration or weight loss.
Discussion
All patients with T1 and T2 laryngeal cancer should be
treated with the intent to preserve the larynx [2, 3]. In T3
glottic low-volume tumors, larynx preservation is one of
the treatment options. Limited stage laryngeal cancer con-
stitutes a wide spectrum of disease. Radiation therapy is
preferred by many clinicians for the treatment of superWcial
tumors with preserved cord mobility, although local control
rates are better in cases with anterior commissural involve-
ment and high volume of the tumor. Supracricoid partial
laryngectomy remains a reasonable alternative for patients
with T2–T3 glottic cancer.
Organ preservation in larynx cancer treatment is one of
the most important goals. The partial procedures, devel-
oped since the sixties, were the mile stones in larynx sur-
gery [4–6]. Supracricoid laryngectomy is one of the
treatment options to the patients with selected laryngeal
cancer with hope of organ preservation. The goal of this
procedure is to preserve physiological speech, swallowing,
and respiration without permanent tracheostomy. The indi-
cations, technique and value of supracricoid laryngectomy
with cricohyoidopexy, a partial laryngeal procedure for
glottic and selected supraglottic and transglottic carcino-
mas, are well known. However, non-surgical approaches
gain the advantage in quality of life scores.
According to Brasnu [7] supracricoid laryngectomy with
CHP is indicated for selected transglottic tumors classiWed
as T2 with invasion of the Xoor of the ventricle and glottis
extension and/or impaired motion of the true vocal cord,
selected transglottic and supraglottic tumors T3 in TNM
classiWcation with vocal cord Wxation and/or preepiglottic
space invasion, selected transglottic and supraglottic
tumors T4 without extension to thyroid perichondrium, and
selected glottic tumors with inWltration to the anterior com-
missure and preepiglottic spaces.
According to the literature, the supracricoid laryngec-
tomy has more extensive indications compared with the
other conservative techniques, selected T3 transglottic car-
cionoma caused by vocal cord Wxation and/or limited pre-
epiglottic space invasion, without invasion of the
arytenoids cartilage according to Laccourreye et al., and
Brasnu et al., and transglottic carcionoma invading the thy-
roid cartilage [4, 5, 7].
According to P. Laudadio [8], the invasion of the ante-
rior commissure with full thickness invasion or even extra-
cartilage spread of the thyroid cartilage itself is not a
contraindication to supracricoid laryngectomy, as the com-
partment is totally resected allowing oncologically safe
margines.
Overall cost of laryngeal preservation strategy (open
partial laryngectomy) requires a few days hospitalization
Fig. 1 Kaplan–Meier survival 
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and results in poorer voice quality compared with either
laser resection or radiotherapy, although there are inconve-
niences associated with a 5 to 6-week course of radiother-
apy [9].
There is no data directly concerned with the length of
hospital stay in patients after supracricoid reconstructive
partial laryngectomy, but the predictors of prolonged stay
after surgery in head and neck cancer patients are well
known: older age, poor functional status, history of alcohol
abuse, chronic obstructive pulmonary disease and diabetes
mellitus. In our group the mean and median length of stay
were, respectively, 21 days and the most common reason of
prolonged hospitalization was diYculties in swallowing
rehabilitation, mostly observed after supracricoid laryngec-
tomy with CHEP or CHP.
In most oncological centers, the cost of radiotherapy is
lower than for partial surgery. Cost of the transoral laser is
similar to the cost of radiotherapy but partial open laryn-
gectomy is signiWcantly more expensive. The approximate
cost of RT (35 sessions) is 1,890D while the cost of partial
laryngectomy is about 5,372D for preoperative study, sur-
gery and 21 days hospitalization, including an intensive
care unit [10]. RT had a local control rate of 79%, which
increased to 90% with salvage surgery and high larynx
preservation rate of 84%; partial laryngectomy had a better
initial local control rate of 84%, which increased to 88%
with salvage surgery [9]. In the Netherlands nearly all
patients were oVered radiotherapy and the mean costs of the
treatment for patients with T2 and T3 carcinoma were
amounted to 8,037 and 12,765D, respectively.
Several options are available to treat laryngeal cancer.
Owing to the functional and social importance of the lar-
ynx, eVorts must be made to preserve its function whenever
possible. Several approaches can be used: partial laryngec-
tomy (open or endoscopic) or radiotherapy (alone or com-
bined with chemotherapy). However, medical approaches
with targeted treatments, surgical options, and radiotherapy
modalities, especially in T2 and T3 glottic cancer, should
have clear inclusion criteria and be better selected for the
proper therapy option. It deWnitely needs more clinical
trials.
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